ACLX

Arcellx, Inc. NASDAQ

Healthcare ·Biotechnology ·US · arcellx.com

$115.07

Mkt Cap $6.7B

52w Low $47.86 99.9% of range 52w High $115.13

50d MA $110.81 200d MA $83.72

P/E (TTM) -28.3x

EV/EBITDA -18.6x

P/B 16.1x

Debt/Equity 0.2x

ROE -56.9%

P/FCF -17.3x

RSI (14) —

ATR (14) —

Beta 0.25

50d MA $110.81

200d MA $83.72

Avg Volume 2.4M

About

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic co…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 26, 2026	AMC	-1.01	-1.01	+0.0%	113.88	+0.1%	-0.1%	+0.1%	+0.1%	+0.4%	+0.4%	—
Nov 5, 2025	AMC	-0.96	-0.99	-3.1%	87.51	-0.0%	+0.8%	-1.1%	-2.1%	+3.1%	+3.0%	—
Aug 7, 2025	AMC	-1.03	-0.94	+8.7%	71.15	-0.6%	-0.9%	-2.9%	+1.9%	-0.2%	+1.0%	—
May 8, 2025	AMC	-0.84	-1.13	-34.5%	56.26	-0.3%	+2.3%	+5.8%	+3.5%	+4.9%	+3.9%	—
Feb 27, 2025	AMC	-0.63	-0.87	-38.1%	61.39	-4.4%	+5.6%	+2.0%	+6.9%	+12.2%	+11.7%	—
Nov 7, 2024	AMC	-0.54	-0.48	+11.1%	99.16	+0.8%	+3.9%	+7.4%	+1.3%	+1.0%	-4.1%	—
Aug 8, 2024	AMC	-0.54	-0.51	+5.6%	52.58	+2.1%	+12.3%	+12.1%	+15.3%	+14.6%	+23.4%	—
May 9, 2024	AMC	-0.51	-0.14	+72.5%	52.73	-1.7%	-5.7%	-5.6%	-4.0%	-1.9%	+0.1%	—
Feb 28, 2024	AMC	-0.61	0.42	+168.9%	67.32	+3.1%	-2.2%	-0.7%	+0.9%	+3.4%	+8.4%	—
Nov 13, 2023	AMC	-0.56	-0.81	-44.6%	45.50	+1.1%	+4.3%	+9.9%	+14.7%	+21.3%	+15.6%	—
Aug 14, 2023	AMC	-0.68	-0.50	+26.5%	33.68	+11.7%	+6.6%	+5.6%	+3.6%	+3.3%	+4.3%	—
May 8, 2023	AMC	2.52	-0.58	-123.0%	43.23	+1.0%	+3.7%	+8.5%	+3.1%	-3.8%	+0.5%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 26	Guggenheim	Downgrade	Buy → Neutral	—	$113.76	$113.80	+0.0%	+0.1%	+0.0%	+0.3%	+0.3%	+0.5%
Feb 24	Citigroup	Downgrade	Buy → Neutral	—	$113.75	$113.78	+0.0%	+0.0%	+0.0%	+0.1%	+0.0%	+0.3%
Feb 24	Stifel	Downgrade	Buy → Hold	—	$113.75	$113.78	+0.0%	+0.0%	+0.0%	+0.1%	+0.0%	+0.3%
Feb 24	Evercore ISI	Downgrade	Outperform → In Line	—	$113.75	$113.78	+0.0%	+0.0%	+0.0%	+0.1%	+0.0%	+0.3%
Feb 24	Truist	Downgrade	Buy → Hold	—	$113.75	$113.78	+0.0%	+0.0%	+0.0%	+0.1%	+0.0%	+0.3%
Feb 24	UBS	Downgrade	Buy → Neutral	—	$113.75	$113.78	+0.0%	+0.0%	+0.0%	+0.1%	+0.0%	+0.3%
Feb 24	Leerink Partners	Downgrade	Outperform → Market Perform	—	$113.75	$113.78	+0.0%	+0.0%	+0.0%	+0.1%	+0.0%	+0.3%
Feb 23	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$64.11	$114.14	+78.0%	+77.4%	+77.4%	+77.4%	+77.6%	+77.5%
Feb 23	HC Wainwright & Co.	Downgrade	Buy → Neutral	—	$64.11	$114.14	+78.0%	+77.4%	+77.4%	+77.4%	+77.6%	+77.5%
Feb 23	Baird	Downgrade	Outperform → Neutral	—	$64.11	$114.14	+78.0%	+77.4%	+77.4%	+77.4%	+77.6%	+77.5%
Feb 23	Needham	Downgrade	Buy → Hold	—	$64.11	$114.14	+78.0%	+77.4%	+77.4%	+77.4%	+77.6%	+77.5%
Feb 5	Needham	Maintains	Buy → Buy	—	$69.38	$70.02	+0.9%	-3.5%	-1.9%	-0.8%	-3.1%	+0.7%
Feb 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$69.46	$70.14	+1.0%	-0.1%	-3.6%	-2.1%	-1.0%	-3.2%
Dec 8	Needham	Maintains	Buy → Buy	—	$69.56	$74.95	+7.7%	+6.5%	+1.8%	+3.5%	+4.5%	+3.3%
Dec 8	Canaccord Genuity	Maintains	Buy → Buy	—	$69.56	$74.95	+7.7%	+6.5%	+1.8%	+3.5%	+4.5%	+3.3%
Nov 3	Canaccord Genuity	Maintains	Buy → Buy	—	$90.25	$89.84	-0.5%	-4.6%	-2.3%	-3.0%	-2.3%	-4.1%
Jul 31	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$71.54	$71.60	+0.1%	-0.2%	-0.6%	+0.8%	+0.7%	-1.2%
Jun 16	HC Wainwright & Co.	Maintains	Buy → Buy	—	$66.00	$66.73	+1.1%	-2.9%	-4.7%	-3.3%	-4.5%	-3.6%
May 9	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$56.26	$56.07	-0.3%	+2.3%	+5.8%	+3.5%	+4.9%	+3.9%
Dec 10	Needham	Maintains	Buy → Buy	—	$82.95	$84.14	+1.4%	-0.8%	+4.9%	+0.6%	+1.0%	+0.6%
Dec 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$82.95	$84.14	+1.4%	-0.8%	+4.9%	+0.6%	+1.0%	+0.6%
Dec 10	UBS	Maintains	Buy → Buy	—	$82.95	$84.14	+1.4%	-0.8%	+4.9%	+0.6%	+1.0%	+0.6%
Dec 9	Needham	Maintains	Buy → Buy	—	$84.55	$88.75	+5.0%	-1.9%	-2.7%	+2.9%	-1.3%	-0.9%
Nov 12	Truist	Maintains	Buy → Buy	—	$106.53	$106.33	-0.2%	-5.7%	-6.0%	-10.7%	-17.6%	-17.2%
Nov 8	Piper Sandler	Maintains	Overweight → Overweight	—	$99.16	$99.94	+0.8%	+3.9%	+7.4%	+1.3%	+1.0%	-4.1%
Nov 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$99.16	$99.94	+0.8%	+3.9%	+7.4%	+1.3%	+1.0%	-4.1%
Nov 8	Needham	Maintains	Buy → Buy	—	$99.16	$99.94	+0.8%	+3.9%	+7.4%	+1.3%	+1.0%	-4.1%
Nov 6	BofA Securities	Maintains	Buy → Buy	—	$87.12	$94.34	+8.3%	+6.7%	+13.8%	+18.3%	+22.3%	+15.3%
Nov 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$87.12	$94.34	+8.3%	+6.7%	+13.8%	+18.3%	+22.3%	+15.3%
Nov 6	Morgan Stanley	Maintains	Overweight → Overweight	—	$87.12	$94.34	+8.3%	+6.7%	+13.8%	+18.3%	+22.3%	+15.3%
Nov 6	Needham	Maintains	Buy → Buy	—	$87.12	$94.34	+8.3%	+6.7%	+13.8%	+18.3%	+22.3%	+15.3%
Nov 6	Baird	Maintains	Outperform → Outperform	—	$87.12	$94.34	+8.3%	+6.7%	+13.8%	+18.3%	+22.3%	+15.3%
Oct 31	Needham	Maintains	Buy → Buy	—	$86.81	$86.42	-0.4%	-2.9%	-0.7%	-0.4%	+0.4%	+7.1%
Oct 22	Needham	Maintains	Buy → Buy	—	$90.28	$89.69	-0.7%	+0.2%	-2.3%	-4.2%	-6.6%	-5.9%
Oct 18	Stifel	Maintains	Buy → Buy	—	$95.27	$95.90	+0.7%	+1.7%	-5.2%	-5.0%	-7.4%	-9.2%
Oct 17	Canaccord Genuity	Maintains	Buy → Buy	—	$93.00	$94.70	+1.8%	+2.4%	+4.2%	-2.9%	-2.7%	-5.2%
Aug 9	Needham	Maintains	Buy → Buy	—	$52.58	$53.70	+2.1%	+12.3%	+12.1%	+15.3%	+14.6%	+23.4%
Jul 22	Canaccord Genuity	Maintains	Buy → Buy	—	$62.56	$63.11	+0.9%	+0.7%	+1.0%	-0.7%	+0.2%	+3.0%
Jun 18	Truist	Maintains	Buy → Buy	—	$53.75	$53.90	+0.3%	+0.1%	+1.6%	+4.4%	+4.3%	+0.1%
May 15	Stifel	Maintains	Buy → Buy	—	$50.62	$52.26	+3.2%	+2.2%	+4.3%	+5.9%	+7.4%	+5.2%
May 13	HC Wainwright & Co.	Maintains	Buy → Buy	—	$49.74	$50.44	+1.4%	+0.1%	+1.8%	+4.0%	+6.1%	+7.8%
May 10	Needham	Maintains	Buy → Buy	—	$52.73	$51.81	-1.7%	-5.7%	-5.6%	-4.0%	-1.9%	+0.1%
May 7	Needham	Maintains	Buy → Buy	—	$52.67	$52.78	+0.2%	-0.5%	-0.8%	+0.1%	-5.6%	-5.5%
Apr 11	Needham	Maintains	Buy → Buy	—	$59.08	$59.54	+0.8%	+1.8%	-1.7%	-3.6%	-6.5%	-9.4%
Mar 18	Needham	Maintains	Buy → Buy	—	$70.62	$70.96	+0.5%	-2.1%	+3.4%	+4.1%	+2.0%	-0.6%
Mar 14	Stifel	Maintains	Buy → Buy	—	$70.55	$70.17	-0.5%	-1.4%	+0.1%	-2.0%	+3.5%	+4.2%
Mar 5	Truist	Maintains	Buy → Buy	—	$67.91	$67.64	-0.4%	+2.5%	+7.4%	+4.2%	+6.5%	+1.4%
Feb 29	HC Wainwright & Co.	Maintains	Buy → Buy	—	$67.32	$69.40	+3.1%	-2.2%	-0.7%	+0.9%	+3.4%	+8.4%
Feb 29	Canaccord Genuity	Maintains	Buy → Buy	—	$67.32	$69.40	+3.1%	-2.2%	-0.7%	+0.9%	+3.4%	+8.4%
Feb 29	Baird	Maintains	Outperform → Outperform	—	$67.32	$69.40	+3.1%	-2.2%	-0.7%	+0.9%	+3.4%	+8.4%